Candida: Difference between revisions
From IDWiki
Candida
m (Aidan moved page Candida to Candida species) |
mNo edit summary |
||
| Line 1: | Line 1: | ||
| + | * Most common medically-important genus of yeast |
||
| − | = Candida spp. = |
||
| + | = Microbiology = |
||
| − | == Identification == |
||
| + | * Budding yeast |
||
| − | * Yeast |
||
| − | + | = Organisms = |
|
* ''C. albicans'' |
* ''C. albicans'' |
||
| Line 14: | Line 14: | ||
* ''C. krusei'' |
* ''C. krusei'' |
||
| − | + | = Infections = |
|
* Most common: mouth, vagina, skin |
* Most common: mouth, vagina, skin |
||
| Line 21: | Line 21: | ||
* IVDU: endocarditis |
* IVDU: endocarditis |
||
| − | + | = Investigations = |
|
* Urine culture if concern for cystitis |
* Urine culture if concern for cystitis |
||
| Line 32: | Line 32: | ||
** Identifies fluconazole-sensitive Candidae |
** Identifies fluconazole-sensitive Candidae |
||
| − | + | = Species and Resistance = |
|
{| |
{| |
||
| Line 62: | Line 62: | ||
* See also [https://doi.org/10.1086/504492 Pharmacology of Systemic Antifungal Agents, CID 2006] |
* See also [https://doi.org/10.1086/504492 Pharmacology of Systemic Antifungal Agents, CID 2006] |
||
| − | + | = Treatment = |
|
* First-line: |
* First-line: |
||
| Line 71: | Line 71: | ||
* Endophthalmitis: extend course to 4 weeks |
* Endophthalmitis: extend course to 4 weeks |
||
* Failure of therapy: double-check for endophthalmitis |
* Failure of therapy: double-check for endophthalmitis |
||
| + | |||
| + | {{DISPLAYTITLE:''Candida'' species}} |
||
| + | [[Category:Yeasts]] |
||
Revision as of 16:02, 13 August 2019
- Most common medically-important genus of yeast
Microbiology
- Budding yeast
Organisms
- C. albicans
- C. dubliniensis
- C. glabrata: Fluconazole-resistant
- C. tropicalis
- C. parapsilosis
- C. krusei
Infections
- Most common: mouth, vagina, skin
- In immunocompromised, ICU, IVDU, or TPN patients: Esophagus, blood, CNS, endophthalmitis
- Less common: joint
- IVDU: endocarditis
Investigations
- Urine culture if concern for cystitis
- Blood culture
- Never ignore candidemia!
- Requires an ophthalmology consult to rule out endophthalmitis (1-3% of cases)
- Echocardiogram if IVDU or prosthetic valve
- Germ tube test (GTT)
- If positive, indicates C. albicans or C. dubliniensis
- Identifies fluconazole-sensitive Candidae
Species and Resistance
| Species | Resistance pattern |
|---|---|
| C. albicans | Generally fluconazole-susceptible |
| C. dubliniensis | Generally fluconazole-susceptible |
| C. parapsilosis | Generally fluconazole-susceptible |
| C. glabrata | Often fluconazole resistant, or dose-dependent |
| C. tropicalis | Generally fluconazole-susceptible |
| C. krusei | Inherent fluconazole resistance |
| C. lusitaniae | Often amphotericin resistant but fluconazole-susceptible |
Treatment
- First-line:
- Remove lines!
- GGT positive: fluconazole for 2 weeks after first negative blood culture
- GGT negative: move to second-line therapies
- Second-line: micafungin, then amphotericin B (last choice)
- Endophthalmitis: extend course to 4 weeks
- Failure of therapy: double-check for endophthalmitis
